Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
3 Thoughts on the FDA’s Final LDTs Rule
Regulatory expert Julie Ballard shares her first thoughts on the final rule for lab-developed tests and immediate steps for labs
Report Highlights Serious Concerns About Marketing of NIPTs
Noninvasive prenatal tests (NIPTs) have taken a lot of flak recently and now a new report is throwing more dirt on the marketing side of these tests. The Hastings Center Report study, released on March 9, assessed all English-language brochures for consumers of...
New Special Prosecutor to Crack Down on COVID-19 Relief Fraud
Weeks after the COVID-19 public health emergency was declared, Congress passed a pair of massive bills—the Families First Coronavirus Response Act (FFCRA) and Coronavirus Aid, Relief, and Economic Security Act (CARES)—providing trillions of dollars in relief for...
Certain Gut Microbes May Identify Pancreatic Cancer Sooner
A specific panel of gut microbes may identify pancreatic cancer, irrespective of how far the disease has progressed, suggests research published online in the journal Gut. The findings offer hope of a new non-invasive method of diagnosing this hard to treat...
The Latest Changes at G2 Intelligence
It’s been busy here at G2 Intelligence as we continue to make improvements to the brand. One change that you’ve likely noticed is that our four monthly briefings—National Lab Reporter, Diagnostic Testing & Emerging Technologies, Lab Compliance Advisor, and...
Labcorp and Walgreens Partner to Provide Free COVID-19 Test Kits
On March 7, global life science company Labcorp and major US retailer Walgreens announced that Labcorp’s Pixel by Labcorp® COVID-19 at-home collection kit will be available at Walgreens locations across the US for free to eligible individuals. The PCR test has...
COVID-19 Revenues Bubble Hasn’t Burst, But It Is Leaking
What a difference a year makes. In Q4 2021, COVID-19 testing demand was cresting and lab companies with COVID-19 products were posting record—and ultimately unsustainable—revenue growth. Compared to this baseline, 15 of the 31 companies that had reported their...
